This CPD activity is supported by an unrestricted education grant by Reckitt.[/caption]
Jess Hadley, community pharmacist and Professional Officer at PDL[/caption]
Peter Guthrey, Senior Pharmacist – Strategic Policy at PSA[/caption]
Professor Margie Danchin[/caption]
Dr Peter Tenni[/caption]
How should we deprescribe gabapentinoids, according to the Maudsley Deprescribing Guidelines[/caption]
Down-scheduling of oral antibiotics could improve patient access, study finds
Immediate patient access to antibiotics through pharmacies has been recognised as a factor in addressing antibiotic misuse in the community, as antimicrobial resistance increases.
A...
Aged care wisdom
More than 200,000 Australians currently live in aged care and the number grows each day. Optimising medicine safety is a crucial concern.
Shifting gears: the pain specialist
Pene Wood is a dedicated pain, addiction and Quality Use of Medicines specialist who works across community pharmacy, policy and education. She has recently...
Engaging hyper-connected patients
At PSA17, I discussed how pharmacists can engage hyper-connected patients to help them avoid misinformation or misadventure. In case you missed it, here are...
From the president: Medicine safety is vital to improving disability care
Last month, I had the pleasure of meeting many of you at our annual PSA22 flagship conference in Sydney, where we also launched our...
Medicines in breast milk
Pharmacists can provide advice to breastfeeding women on using medicines that are compatible with breastfeeding and on how to minimise infant exposure to medicines...
